[go: up one dir, main page]

Hurwitz et al., 1985 - Google Patents

The covalent linking of two nucleotide analogs to antibodies

Hurwitz et al., 1985

Document ID
10108500991200418558
Author
Hurwitz E
Kashi R
Arnon R
Wilchek M
Sela M
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Two anticancer drugs, antagonists of nucleic acids, were covalently linked to antibodies specifically reactive with B leukemia cells and thus with a potential possibility of drug targeting to the tumorsite. The drugs cytosine l-/3-D-arabinoside and 5-fluorouridine …
Continue reading at pubs.acs.org (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48369Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Raso et al. Hybrid antibodies with dual specificity for the delivery of ricin to immunoglobulin-bearing target cells
Hurwitz et al. The covalent linking of two nucleotide analogs to antibodies
Lichtenstein et al. In vitro tumor cell cytolysis mediated by peptide defensins of human and rabbit granulocytes
FI102355B (en) Process for the preparation of anthracycline immunoconjugates with the same binding link
US5028697A (en) Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US4401592A (en) Pharmaceutical composition having antitumor activity
Clark et al. Exofacial photolabelling of the human erythrocyte glucose transporter with an azitrifluoroethylbenzoyl-substituted bismannose
Forbes et al. Mannose 6-, fructose 1-, and fructose 6-phosphates inhibit human natural cell-mediated cytotoxicity.
EP0259904A1 (en) Advanced anticancer therapy and cytotoxic medicaments for its implementation
SE462261B (en) PHARMACEUTICAL COMPOSITION AND CONJUGATED OF MELFALAN AND NORMAL HUMANIMMUNOGLOBULIN WITH ANTITUMUM EFFECTS AND PROCEDURES FOR ITS PREPARATION
US5840880A (en) Receptor modulating agents
WO1995027723A1 (en) Receptor modulating agents and methods relating thereto
JPH03502885A (en) Method of treating tumor cells by inhibiting growth factor receptor function
EA001200B1 (en) PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT, METHOD OF INHIBITING IMMUNE RESPONSE
Melmon et al. Separation of specific antibody-forming mouse cells by their adherence to insolubilized endogenous hormones
Chess et al. Leukocyte inhibitory factor (LIF): Production by purified human T and B lymphocytes
KR20030088056A (en) Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
JPS5843926A (en) Selective carcinostatic agent
Newman Selective blockade of human natural killer cells by a monoclonal antibody.
Edmiston et al. In vivo induction of murine cytokine production by carcinoembryonic antigen
Connors et al. Studies on the mechanism of action of 5‐aziridinyl‐2, 4‐dinitrobenzamide (CB 1954), a selective inhibitor of the walker tumour
Rosowsky Methotrexate analogs. 2. Facile method of preparation of lipophilic derivatives of methotrexate and 3', 5'-dichloromethotrexate by direct esterification
JPH08501535A (en) Peptide drugs for treating diseases
US5739287A (en) Biotinylated cobalamins
US5284834A (en) Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same